MeSH term
Frequency | Condition_Probility | China | 3 | 0.0 |
DNA/genetics | 4 | 0.0 |
English Abstract | 6 | 0.0 |
Family Health | 3 | 0.0 |
Female | 58 | 0.0 |
Gene Frequency | 5 | 0.0 |
Genetic Markers/genetics | 5 | 1.0 |
Genotype | 3 | 0.0 |
Hemophilia A/*genetics | 8 | 38.0 |
*Heterozygote | 3 | 0.0 |
Heterozygote Detection/methods | 4 | 16.0 |
Humans | 75 | 0.0 |
Male | 48 | 0.0 |
Minisatellite Repeats/*genetics | 3 | 4.0 |
Pedigree | 42 | 0.0 |
Polymorphism, Genetic | 12 | 0.0 |
Polymorphism, Restriction Fragment Length | 18 | 0.0 |
Research Support, Non-U.S. Gov't | 44 | 0.0 |
X Chromosome/*genetics | 2 | 0.0 |
Chromosome Mapping | 15 | 0.0 |
Factor VIII/*genetics | 8 | 21.0 |
Hemophilia A/*diagnosis/genetics | 5 | 45.0 |
*Linkage (Genetics) | 22 | 1.0 |
Alleles | 10 | 0.0 |
*Minisatellite Repeats | 3 | 3.0 |
*Polymorphism, Genetic | 14 | 0.0 |
*X Chromosome | 30 | 3.0 |
*Alleles | 3 | 0.0 |
Heterozygote | 4 | 0.0 |
India/epidemiology | 2 | 2.0 |
Prenatal Diagnosis | 4 | 2.0 |
DNA/analysis | 7 | 0.0 |
*Heterozygote Detection | 9 | 8.0 |
Korea | 2 | 0.0 |
Minisatellite Repeats | 2 | 1.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Pregnancy | 11 | 0.0 |
Linkage (Genetics) | 14 | 0.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Heterozygote Detection/*methods | 3 | 5.0 |
*Chromosome Mapping | 10 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
Factor VIII/genetics | 6 | 50.0 |
Mutation | 4 | 0.0 |
*Polymorphism, Restriction Fragment Length | 13 | 1.0 |
Base Sequence | 8 | 0.0 |
Genetic Markers | 17 | 0.0 |
X Chromosome | 7 | 1.0 |
Hemophilia A/diagnosis/*genetics | 4 | 80.0 |
Animals | 6 | 0.0 |
Blotting, Southern | 3 | 0.0 |
DNA Probes | 9 | 0.0 |
*Gene Frequency | 2 | 0.0 |
Factor IX/*genetics | 2 | 7.0 |
Heterozygote Detection | 6 | 1.0 |
Abnormalities, Multiple/genetics | 2 | 2.0 |
Adult | 10 | 0.0 |
Middle Aged | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Syndrome | 5 | 0.0 |
Thumb/abnormalities | 2 | 14.0 |
Adolescent | 3 | 0.0 |
Child | 5 | 0.0 |
Haplotypes | 3 | 0.0 |
Infant | 3 | 0.0 |
Infant, Newborn | 3 | 0.0 |
Lod Score | 8 | 0.0 |
Muscular Dystrophies/*genetics | 4 | 4.0 |
Muscular Dystrophy, Emery-Dreifuss | 2 | 40.0 |
Child, Preschool | 3 | 0.0 |
Karyotyping | 4 | 0.0 |
Phenotype | 4 | 0.0 |
Fetal Diseases/diagnosis/genetics | 2 | 20.0 |
*Prenatal Diagnosis | 4 | 1.0 |
Risk | 2 | 0.0 |
Fragile X Syndrome/*genetics | 11 | 7.0 |
Genetic Counseling | 2 | 1.0 |
*Genes, Recessive | 2 | 1.0 |
Chromosome Banding | 4 | 0.0 |
Gene Library | 2 | 0.0 |
Genome, Human | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Hybrid Cells | 4 | 0.0 |
Nucleic Acid Hybridization | 3 | 0.0 |
Nucleotide Mapping | 2 | 4.0 |
Chromosome Deletion | 4 | 0.0 |
Multigene Family | 2 | 0.0 |
X Chromosome/*ultrastructure | 5 | 20.0 |
*DNA Probes | 3 | 6.0 |
*Deoxyribonucleases, Type II Site-Specific | 2 | 3.0 |
Sex Chromosome Aberrations/*genetics | 14 | 22.0 |
*Chromosome Fragility | 3 | 2.0 |
Inversion, Chromosome | 2 | 3.0 |
Recombination, Genetic | 7 | 0.0 |
Chromosome Fragile Sites | 2 | 1.0 |
Factor IX/genetics | 4 | 19.0 |
*Genetic Markers | 6 | 1.0 |
DNA/*genetics | 5 | 1.0 |
DNA/*analysis | 2 | 0.0 |
Mice | 2 | 0.0 |
DNA Restriction Enzymes | 6 | 1.0 |
*Recombination, Genetic | 3 | 0.0 |
